ACC.25: Focus on ATTR-CM
ACC.25: Focus on ATTR-CM
Advertisement
Rob DillardACC.25: Focus on ATTR-CM | April 29, 2025
A multifaceted approach is necessary to reduce the deaths of smoking-related aortic aneurysms.
Read More
Rob DillardACC.25: Focus on ATTR-CM | April 29, 2025
Many preschool-aged children with congenital heart conditions are not on track for school readiness.
Rob DillardACC.25: Focus on ATTR-CM | April 17, 2025
Sudden cardiac death increases amid lower daily temperatures.
Rob DillardACC.25: Focus on ATTR-CM | April 17, 2025
Acoramidis therapy significantly increases serum transthyretin in people with ATTR-CM compared with tafamidis.
Rob DillardACC.25: Focus on ATTR-CM | April 17, 2025
Patients with single ventricle heart disease commonly have mental health diagnoses.
Rob DillardACC.25: Focus on ATTR-CM | April 17, 2025
Acoramidis therapy induces a significant increase in serum transthyretin, which is typically lower in ATTRv-CM.
Advertisement
Advertisement